Huasaiboman Medical Cell Biology

Huasaiboman Medical Cell Biology is a biotechnology company engaged in providing new cell therapy technologies and solutions.

Health and bio

Latest funding

$29.97M Series B+ · November 9, 2026

Led by Zhangjiang Science & Technology Investment Corporation · Source: donews.com

Funding history ↓

Website: sino-cellbiomed.com.

Category: Health and bio.

Sectors: Biotechnology, Life Science, Medical, Pharmaceutical.

Stage: Series B+.

Based in: Qingdao Shi, China.

Last round: Nov 9, 2026 · 3 days ago.

On Recent Funding since: Nov 10, 2026.

Signals

Website registeredNov 27, 2018 (8 years old)

Funding rounds

November 9, 2026
Series B+ · $29.97M
ZZhangjiang Science & Technology Investment Corporation (lead), FFeixi Industrial Investment, GGuoxin Investment, HHeda Investment, HHefei Guotou, HHefei Industrial Investment Group Life and Health Company, HHengze Capital
Source: donews.com
November 27, 2018
Website created

Investors

Companies like Huasaiboman Medical Cell Biology

NNewLimit$435M Series B+ · Jun 2026
1100XBIOPre Seed · Oct 2026
MMyeloid TherapeuticsSeries B+ · May 2026
EEurekaBio$40M Series B+ · Mar 2024
CCellaresSeries B+ · Jul 2026
AAspen Neuroscience$115M Series B+ · Nov 2025

Other companies backed by Zhangjiang Science & Technology Investment Corporation

ZZhenTec TechnologySeries B+ · Nov 2026
LLingshu Intelligent TechnologySeries A · Oct 2026

Zhangjiang Science & Technology Investment Corporation portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/huasaiboman-medical-cell-biology (get a free API key).